User profiles for S. Wu

Sanfeng Wu

- Verified email at princeton.edu - Cited by 13721

Shinyi Wu, PhD

- Verified email at usc.edu - Cited by 8380

Shuang Wu

- Verified email at nvidia.com - Cited by 3915

Systematic review: impact of health information technology on quality, efficiency, and costs of medical care

B Chaudhry, J Wang, S Wu, M Maglione… - Annals of internal …, 2006 - acpjournals.org
Background: Experts consider health information technology key to improving efficiency and
quality of health care. Purpose: To systematically review evidence on the effect of health …

[HTML][HTML] Clinical and immunological features of severe and moderate coronavirus disease 2019

…, S Wu, J Song, T Chen, M Han, S Li… - The Journal of …, 2020 - Am Soc Clin Investig
… with the unpaired 2-sided Student’s t test; categorical variables were expressed as number
(%) and compared by χ 2 test or Fisher’s exact test between moderate and severe case …

Deep learning for visual understanding: A review

Y Guo, Y Liu, A Oerlemans, S Lao, S Wu, MS Lew - Neurocomputing, 2016 - Elsevier
Deep learning algorithms are a subset of the machine learning algorithms, which aim at
discovering multiple levels of distributed representations. Recently, numerous deep learning …

[HTML][HTML] Deep speech 2: End-to-end speech recognition in english and mandarin

…, X Li, D Ma, S Narang, A Ng, S Ozair… - International …, 2016 - proceedings.mlr.press
We show that an end-to-end deep learning approach can be used to recognize either English
or Mandarin Chinese speech–two vastly different languages. Because it replaces entire …

Polymer/silica nanocomposites: preparation, characterization, properties, and applications

H Zou, S Wu, J Shen - Chemical reviews, 2008 - ACS Publications
… during the polymerization of the monomer(s); the method of in situ polymerization involves
the dispersion of nanosilica in the monomer(s) first and then polymerization is carried out. In …

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

SR Nalluri, D Chu, R Keresztes, X Zhu, S Wu - Jama, 2008 - jamanetwork.com
… Author Contributions: Dr Wu had full access to all of the data in the study and takes … Financial
Disclosures: Dr Wu reported being a speaker for Pfizer Inc, receiving honoraria from Onyx …

Stroke in China: advances and challenges in epidemiology, prevention, and management

S Wu, BO Wu, M Liu, Z Chen, W Wang… - The Lancet …, 2019 - thelancet.com
With over 2 million new cases annually, stroke is associated with the highest disability-adjusted
life-years lost of any disease in China. The burden is expected to increase further as a …

[HTML][HTML] Antibody responses to SARS-CoV-2 in patients with COVID-19

QX Long, BZ Liu, HJ Deng, GC Wu, K Deng, YK Chen… - Nature medicine, 2020 - nature.com
We report acute antibody responses to SARS-CoV-2 in 285 patients with COVID-19. Within
19 days after symptom onset, 100% of patients tested positive for antiviral immunoglobulin-G …

[PDF][PDF] Generation of induced pluripotent stem cells using recombinant proteins

…, S Wu, JY Joo, S Zhu, DW Han, T Lin, S Trauger… - Cell stem cell, 2009 - cell.com
Groundbreaking work demonstrated that ectopic expression of four transcription factors, Oct4,
Klf4, Sox2, and c-Myc, could reprogram murine somatic cells to induced pluripotent stem …

[HTML][HTML] Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort …

…, Q Yang, S Wu, J Fan, B Shu, Z Hu, S Wang… - The Lancet …, 2020 - thelancet.com
Background COVID-19 has spread globally. Epidemiological susceptibility to COVID-19 has
been reported in patients with cancer. We aimed to systematically characterise clinical …